Company: LCTX
Filing Date: 2025-01-27
Form Type: 8-K
Source: 0000950170-25-009227
Chunk: 3

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-01-27
Form: 8-K
Item: Item 8.01
Chunk 3
---
.

The securities described above were offered and sold by Lineage in a registered direct offering pursuant to a “shelf” registration statement on Form S-3 (File No. 333-277758) filed with the SEC on March 7, 2024, and which was declared effective by the SEC on May 14, 2024. The offering of the securities in the registered direct offering was made only by means of a base prospectus and a prospectus supplement that forms a part of the effective registration statement. A final prospectus supplement and the accompanying base prospectus relating to the offering were filed with the SEC and are available on the SEC’s website at www. sec. gov.

Item 9.01 Financial Statements and Exhibits.